Armed with a recent $30 million funding found, Obalon Therapeutics launches a pivotal trial for its ingestible weight loss balloon.
California's Obalon Therapeutics said it launched a pivotal trial set for as many as 15 sites across the U.S. that will test its ingestible, gas-filled weight-loss balloon.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/19qg86d
Cap comentari:
Publica un comentari a l'entrada